VMTHF OTC
Venus Medtech (Hangzhou), Inc. Class H
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +57.4%
1Y: -18.8%
3Y: -74.6%
$0.42
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3.2B
-26.4% ▼
5Y CAGR: -2.4%
Total Liabilities
$1.0B
-30.5% ▼
5Y CAGR: +142.6%
Shareholders Equity
$2.2B
-24.3% ▼
5Y CAGR: -6.2%
Cash & Investments
$306M
-60.9% ▼
5Y CAGR: -33.8%
Total Debt
$369M
-55.3% ▼
5Y CAGR: +21.9%
Net Debt
$71M
+37.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.7B | $3.0B | $1.9B | $774M | $298M |
| Short-Term Investments | $44M | $0 | $0 | $7M | $8M |
| Cash & ST Investments | $2.8B | $3.0B | $1.9B | $782M | $306M |
| Net Receivables | $231M | $302M | $303M | $291M | $331M |
| Inventory | $60M | $91M | $104M | $113M | $98M |
| Other Current Assets | $304M | $91M | $181M | $376M | $52M |
| Total Current Assets | $3.4B | $3.4B | $2.5B | $1.6B | $802M |
| Property, Plant & Equip. | $110M | $262M | $472M | $693M | $524M |
| Goodwill & Intangibles | $736M | $826M | $1.9B | $1.6B | $1.5B |
| Long-Term Investments | $65M | $574M | $477M | $503M | $407M |
| Other Non-Current Assets | $46M | -$33K | $4M | $34M | $9M |
| Total Non-Current Assets | $958M | $1.7B | $2.8B | $2.8B | $2.4B |
| Total Assets | $4.3B | $5.1B | $5.3B | $4.4B | $3.2B |
| — Liabilities — | |||||
| Accounts Payable | $5M | $9M | $9M | $34M | $30M |
| Short-Term Debt | $0 | $5M | $223M | $457M | $18M |
| Deferred Revenue | $0 | $163M | $0 | $0 | $0 |
| Other Current Liabilities | $352M | -$28M | $192M | $241M | $3M |
| Total Current Liabilities | $406M | $209M | $492M | $805M | $362M |
| Long-Term Debt | $0 | $0 | $573M | $249M | $265M |
| Other Non-Current Liab. | $0 | $167M | $488M | $338M | $364M |
| Total Non-Current Liabilities | $56M | $269M | $1.2B | $689M | $677M |
| Total Liabilities | $461M | $478M | $1.7B | $1.5B | $1.0B |
| — Equity — | |||||
| Common Stock | $423M | $441M | $441M | $441M | $441M |
| Retained Earnings | -$747M | -$1.1B | -$2.2B | -$2.9B | -$3.6B |
| Accumulated OCI | $200M | $185M | $305M | $322M | $326M |
| Total Stockholders Equity | $3.8B | $4.5B | $3.6B | $2.9B | $2.2B |
| Total Liabilities & Equity | $4.3B | $5.1B | $5.3B | $4.4B | $3.2B |
| — Key Metrics — | |||||
| Total Debt | $33M | $71M | $900M | $826M | $369M |
| Net Debt | -$2.7B | -$2.9B | -$980M | $52M | $71M |
| Total Investments | $109M | $574M | $477M | $510M | $415M |